COMBINATION OF A PD-1 ANTAGONIST, AN ATR INHIBITOR AND A PLATINATING AGENT FOR THE TREATMENT OF CANCER

The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises a PD-1 antagonist, an ATR inhibitor and a platinating agent. La présente invention concerne des polythérapies utiles pour le tr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FALK, MARTIN, TADJALLI MEHR, KEYVAN, SOULARD, PATRICIA, ZIMMERMANN, ASTRID, ZENKE, FRANK, ALIMZHANOV, MARAT, DAHMEN, HEIKE, SCHROEDER, ANDREAS
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises a PD-1 antagonist, an ATR inhibitor and a platinating agent. La présente invention concerne des polythérapies utiles pour le traitement du cancer. En particulier, l'invention concerne une combinaison thérapeutique qui comprend un antagoniste de PD-1, un inhibiteur d'ATR et un agent de platination.